Immutable evidence record · ticker
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Published as observed on 18 August 2026 at 03:26 BST.
Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 18 Aug 2026, 03:26
- Scope
- company and instrument
- Evidence
- 22 items
- Independent sources
- 1
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-18, https://sharemaestro.com/evidence/5a7986c6-dbe7-4d70-b543-e6f451a01c59/
Record checksum 0170cf11c1321e0524719896b61ea431f1aeb2cf5fcb66a12e3351c317bcc9e7
